In glioblastoma patients pre-RT, the mean ± SD of serum HIF-1α was 2.61 ± 1.94 that was increased to 4.34 ± 3.30 post-RT, while it was 1.41 ± 0.32 in healthy controls. This evidence concerns the gene HIF1A and glioblastoma.